Search
for

    Sort by

    Research 17

    1. Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management The Neurologist · 2002 · 45 citations
    2. An industry update: what’s new in the field of therapeutic delivery this month? Therapeutic Delivery · 2016
    3. Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management Multiple Sclerosis Journal · 2004 · 37 citations
    4. Teriflunomide and Its Mechanism of Action in Multiple Sclerosis Drugs · 2014 · 253 citations
    5. Teriflunomide in multiple sclerosis: an update Neurodegenerative disease management · 2016 · 20 citations
    6. Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA 2011 · 10 citations
    7. AN SYNOPTIC OVERVIEW ON AUTOIMMUNE DISORDERS AND ITS MANAGEMENT International Journal of Biology Pharmacy and Allied Sciences · 2022
    8. AN SYNOPTIC OVERVIEW ON AUTOIMMUNE DISORDERS AND ITS MANAGEMENT International Journal of Biology Pharmacy and Allied Sciences · 2021
    9. NEW PROPRIETARY BRANDS: Gabapentin Australian Prescriber · 2004
    10. NEW PROPRIETARY BRANDS: Cephalexin Australian Prescriber · 2004
    11. New drugs: Agalsidase beta Australian Prescriber · 2004
    12. NEW FORMULATIONS: Sodium cromoglycate Australian Prescriber · 2004
    13. NEW PROPRIETARY BRANDS: Cefaclor monohydrate Australian Prescriber · 2004
    14. NEW FORMULATIONS: Glatiramer acetate Australian Prescriber · 2004
    15. Catalytic Antibodies in Norm and Systemic Lupus Erythematosus InTech eBooks · 2017 · 25 citations
    16. Combined drug triads for synergic neuroprotection in retinal degeneration Biomedicine & pharmacotherapy · 2022 · 6 citations
    17. Hair Cortisol as a Biomarker of Chronic Stress in Community-Dwelling Adults With Longstanding Multiple Sclerosis Western Journal of Nursing Research · 2026